rvu120
ryvu therapeutics
['mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'rvu120 ']
guten morgen wien! the #eha2022 congress is underway right now, and we are here on-site to present, e.g., the promising results from our ongoing phase 1b dose-escalation study of #rvu120 in patients with aml and hr-mds.
read more: #discoverforpatients 
Ryvu Therapeutics is developing novel small molecule therapies that address clinical limitations of current treatments in oncology.